T. Rowe Price Associates
TWST icon

T. Rowe Price Associates’s Twist Bioscience TWST Stock Holding History

T. Rowe Price Associates’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$374M Buy
3,634,652
+3,564,347
+5,070% +$232M 0.04% 340
2026
Q1 		$3.34M Buy
70,305
+11,320
+19% +$508K ﹤0.01% 1604
2025
Q4 		$1.87M Buy
58,985
+5,135
+10% +$160K ﹤0.01% 1784
2025
Q3 		$1.52M Buy
53,850
+4,566
+9% +$138K ﹤0.01% 1863
2025
Q2 		$1.81M Buy
49,284
+3,527
+8% +$122K ﹤0.01% 1681
2025
Q1 		$1.8M Buy
45,757
+4,356
+11% +$196K ﹤0.01% 1653
2024
Q4 		$1.92M Buy
41,401
+5,554
+15% +$251K ﹤0.01% 1667
2024
Q3 		$1.62M Buy
35,847
+1,100
+3% +$52.3K ﹤0.01% 1740
2024
Q2 		$1.71M Buy
34,747
+2,620
+8% +$107K ﹤0.01% 1633
2024
Q1 		$1.1M Buy
32,127
+2,292
+8% +$82.7K ﹤0.01% 1870
2023
Q4 		$1.1M Sell
29,835
-530,122
-95% -$12.3M ﹤0.01% 1826
2023
Q3 		$11.3M Sell
559,957
-21,683
-4% -$476K ﹤0.01% 1055
2023
Q2 		$11.9M Buy
581,640
+180,411
+45% +$2.7M ﹤0.01% 1049
2023
Q1 		$6.05M Sell
401,229
-323,023
-45% -$7.14M ﹤0.01% 1141
2022
Q4 		$17.2M Sell
724,252
-86,971
-11% -$2.52M ﹤0.01% 951
2022
Q3 		$28.6M Sell
811,223
-447,171
-36% -$19M ﹤0.01% 798
2022
Q2 		$44M Buy
1,258,394
+120,489
+11% +$4.27M 0.01% 915
2022
Q1 		$56.2M Buy
1,137,905
+222,676
+24% +$12.3M 0.01% 932
2021
Q4 		$70.8M Sell
915,229
-123,529
-12% -$12.7M 0.01% 877
2021
Q3 		$111M Sell
1,038,758
-5,998
-0.6% -$687K 0.01% 732
2021
Q2 		$139M Buy
1,044,756
+86,849
+9% +$10.1M 0.01% 671
2021
Q1 		$119M Sell
957,907
-13,070
-1% -$1.98M 0.01% 720
2020
Q4 		$137M Buy
970,977
+317,301
+49% +$35.2M 0.01% 622
2020
Q3 		$49.7M Buy
653,676
+174,094
+36% +$10.8M 0.01% 874
2020
Q2 		$21.7M Buy
479,582
+472,790
+6,961% +$17M ﹤0.01% 1120
2020
Q1 		$208K Buy
+6,792
New +$183K ﹤0.01% 2307

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

T. Rowe Price Associates's TWST Position: Q2 2026 in Review

T. Rowe Price Associates increased its Twist Bioscience (TWST) stake by 5,070% in Q2 2026, buying an estimated $232M and bringing the position to 3,634,652 shares worth $374M. The position accounts for 0.04% of the portfolio, ranked #340.

T. Rowe Price Associates first reported a position in TWST in Q1 2020 and has held it in 26 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • T. Rowe Price Associates held 3,634,652 shares of Twist Bioscience worth $374M as of Q2 2026.
  • T. Rowe Price Associates bought 3,564,347 Twist Bioscience shares in Q2 2026, an estimated $232M.
  • Twist Bioscience made up 0.04% of T. Rowe Price Associates's portfolio in Q2 2026, its #340 holding.
  • T. Rowe Price Associates first reported a position in Twist Bioscience in Q1 2020 and has held it in 26 quarters since.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.